Related content

Impact of Postprandial Remnant Lipoproteins on Coronary Artery Disease

By  

Vascular Disease Prevention, Vol. 1, Iss. 1, 2004-01 ,pp. : 65-68

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of celiprolol and simvastatin on the calculated risk of coronary heart disease (the Celisimva study)

By Olkinuora Jyrki   Viikari Jorma   Vanhanen Hannu   Makkonen Niina   Kalliomäki Tero  

Scandinavian Cardiovascular Journal, Vol. 40, Iss. 3, 2006-06 ,pp. : 160-166

Informa Healthcare

Access to resources Recommend Favorite

The Lescol^® Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease

By Serruys Patrick WJC   de Feyter Pim J   Benghozi Renée   Hugenholtz Paul G   Lesaffre Emmanuel  

International Journal of Cardiovascular Interventions, Vol. 4, Iss. 4, 2001-12 ,pp. : 165-172

Informa Healthcare

Access to resources Recommend Favorite

Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study

By Athyros Vasilios G.   Mikhailidis Dimitri P.   Papageorgiou Athanasios A.   Bouloukos Vasilios I.   Pehlivanidis Anthimos N.   Symeonidis Athanasios N.   Kakafika Anna I.   Daskalopoulou Stella S.   Elisaf Moses  

Platelets, Vol. 16, Iss. 2, 2005-03 ,pp. : 65-71

Informa Healthcare

Access to resources Recommend Favorite

Statins for Secondary Stroke Prevention in Patients without Known Coronary Heart Disease: The Jury Is Still Out

By  

Cerebrovascular Diseases, Vol. 18, Iss. 1, 2004-12 ,pp. : 1-2

Karger

Access to resources Recommend Favorite